The Bruyère Deprescribing Guidelines Research Team has developed an app to grant easy, on-demand access to its deprescribing algorithms — complementary to the resources on this website.
EMPOWER brochures help patients understand the rationale for deprescribing certain medications and explain why it is important to talk to a health care provider about deprescribing
Reducing medications safely to meet life’s changes
What medications were good then might not be the best choice now. Deprescribing is the planned process of reducing or stopping medications that may no longer be of benefit or may be causing harm. The goal is to reduce medication burden or harm while improving quality of life.
Be part of the change for a better quality of life
Learn about deprescribing and check out resources to help you discuss deprescribing with your health care provider.
Health Care Providers
Get comfortable deprescribing with tools and resources, case reports and testimonials, and relevant publications.
As the population ages, older Canadians are living with multiple chronic conditions. In 2016, 35% of community-dwelling seniors had chronic use of 5 or more different drug classes.
Inappropriate prescriptions are known to pose health risks for older adults, leading to unnecessary hospitalisations and undue cost.
“It is an art of no little importance to administer medicines properly; but it is an art of much greater and more difficult acquisition to know when to suspend or altogether omit them.”
Dr. Barbara Farrell, has been awarded the 2019 CIHR Betty Havens Prize for Knowledge Translation in Aging
Congratulations to Dr. Barbara Farrell, who has been awarded the 2019 Canadian Institutes of Health Research (CIHR) Betty Havens Prize for Knowledge Translation in Aging! The Betty Havens Prize is awarded to researchers for their outstanding achievements in...
May 5, 2019 - Doctors are warning that millions of Canadians are taking a commonly prescribed class of drugs used to treat acid reflux much longer than the recommended two-month period, upping the risk of a number of health-related side-effects. Read more
The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built...
Keep up with the latest
New grant paves the way for integrating pharmacists into a telehealth model to support medication management and… twitter.com/i/web/status/1…
“There is a critical need to identify high‐risk populations and high‐impact interventions to reduce fall rates amon… twitter.com/i/web/status/1…
Public engagement campaign aims to raise awareness towards opioid addiction and tackle the high rate of opioid pres… twitter.com/i/web/status/1…